Log In
BCIQ
Print this Print this
 

biosimilar pegfilgrastim (B12019)

  Manage Alerts
Collapse Summary General Information
Company Infarco Group
DescriptionBiosimilar of Neulasta pegfilgrastim, a pegylated G-CSF
Molecular Target Granulocyte colony-stimulating factor (G-CSF) receptor (CSF3R) (CD114)
Mechanism of ActionGranulocyte colony stimulating factor (G-CSF) receptor (CD114) agonist; Biosimilar
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I
Standard IndicationNeutropenia
Indication DetailsTreat chemotherapy-induced neutropenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today